Compare HLN & CLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLN | CLS |
|---|---|---|
| Founded | 2022 | 1994 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Electrical Products |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7B | 37.7B |
| IPO Year | N/A | 1999 |
| Metric | HLN | CLS |
|---|---|---|
| Price | $9.27 | $420.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 15 |
| Target Price | N/A | ★ $404.13 |
| AVG Volume (30 Days) | ★ 6.6M | 2.3M |
| Earning Date | 02-26-2026 | 04-27-2026 |
| Dividend Yield | ★ 1.94% | N/A |
| EPS Growth | N/A | ★ 98.34 |
| EPS | N/A | ★ 1.83 |
| Revenue | N/A | ★ $12,390,900,000.00 |
| Revenue This Year | $6.55 | $41.81 |
| Revenue Next Year | $4.42 | $39.95 |
| P/E Ratio | ★ $49.05 | $229.86 |
| Revenue Growth | N/A | ★ 28.46 |
| 52 Week Low | $8.71 | $90.00 |
| 52 Week High | $11.42 | $426.55 |
| Indicator | HLN | CLS |
|---|---|---|
| Relative Strength Index (RSI) | 35.27 | 64.71 |
| Support Level | $9.01 | $257.27 |
| Resistance Level | $9.96 | N/A |
| Average True Range (ATR) | 0.13 | 20.27 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 24.54 | 92.13 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Celestica Inc offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, The Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.